Llwytho...
Residual Risk of Breast Cancer Recurrence 5 Years After Adjuvant Therapy
There is limited prognostic information to identify breast cancer patients who are at risk for late recurrences after adjuvant or neoadjuvant systemic therapy (AST). We evaluated the residual risk of recurrence and prognostic factors of 2838 patients with stage I–III breast cancer who were treated w...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | J Natl Cancer Inst |
|---|---|
| Prif Awduron: | , , , , , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Oxford University Press
2008
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6592411/ https://ncbi.nlm.nih.gov/pubmed/18695137 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djn233 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|